G6PC1 and Insulin resistance: However, in insulin resistance, reduced IRS-1/PI3K-Akt signaling fails to inhibit FOXO1, leading to excessive expression of phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase), which drive hepatic glucose overproduction (52).